Potential drug treatment for particular type of lung-cancer
The effectiveness of cancer treatment is often hampered by cancer cells being heterogeneous. This is…
Browsing: tyrosine kinase inhibitor
Early prediction of resistance to tyrosine kinase inhibitors in NSCLC
A study published in the journal Oncotarget has reported that at clinical progression, 64 EGFR T790M plasma positive…
ESMO 2018: Avelumab plus axitinib significantly improve PFS in untreated renal cell carcinoma
A combination of the immune checkpoint blocker, , plus the tyrosine kinase inhibitor (TKI), axitinib,…